John Harris, MD
Dermatology · Worcester, MANPI 1316007214
Payments from drug & device makers
What this record shows
This record is dominated by other: $14,819,404 of the $14,978,311 with a category attached, or 98.9%. Incyte Corporation accounts for 99.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $11,402,504 and has fallen 99.9% since, to $14,317 in 2025. Among dermatology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $118,875 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$14.9M
- AbbVie$30K
- Pfizer$22K
- Almirall LLC$10K
- Regeneron$9K
- Janssen Global Services, LLC$4K
- plus $6K from 8 others
Across 151 payments — averaging $14,419 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$736K
- LEO Pharma AS$630K
- Pfizer$360K
- Sanofi US Services Inc.$230K
- Sun Pharmaceutical Industries Inc.$132K
- EMD Serono, Inc.$89K
What the payments were for
- Consulting fees$97,9471%
- Speaking & faculty fees$54,3430%
- Travel & lodging$5,0980%
- Food & beverage$1,5180%
- Other$14,819,40499%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 71 | $14,898,412 |
| AbbVie | 16 | $30,093 |
| Pfizer | 13 | $21,770 |
| Almirall LLC | 7 | $9,796 |
| Regeneron | 7 | $9,147 |
| Janssen Global Services, LLC | 4 | $3,547 |
| LEO Pharma Inc. | 1 | $2,000 |
| Sanofi-aventis U.S. LLC | 1 | $1,848 |
| Sanofi US Services Inc. | 1 | $845 |
| Merck | 1 | $750 |
| Sun Pharmaceutical Industries Inc. | 1 | $33 |
| Boehringer Ingelheim | 1 | $29 |
| Boston Scientific | 1 | $26 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,978,311 in reported general payments places this provider in the 95th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Worcester
- Seth KatesWorcester$64K
- Mehdi Rashighi FiroozabadiWorcester$19K
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.